All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10284342" target="_blank" >RIV/00216208:11110/14:10284342 - isvavai.cz</a>

  • Alternative codes found

    RIV/61383082:_____/14:#0000272 RIV/00216224:14110/14:00075468 RIV/65269705:_____/14:00062681 RIV/00023001:_____/14:00059022 RIV/75010330:_____/14:00010739

  • Result on the web

    <a href="http://dx.doi.org/10.1111/jvh.12248" target="_blank" >http://dx.doi.org/10.1111/jvh.12248</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/jvh.12248" target="_blank" >10.1111/jvh.12248</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

  • Original language description

    The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the modelwas used to estimate the change in the total number of HCV infections, the disease progression and mortality in 2013-2030. Finally, expert panel consensus was used to capture current treatment practices in each country. Using today's treatment paradigm,the total number of HCV infections is projected to decline or remain flat in all countries studied. However, in the same time period, the number of individuals with late-stage liver disease is projected to increase. This study concluded that the currenttreatment rate and efficacy are not sufficient to manage the disease burden of HCV. Thus, alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver-related deaths from increasing.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Viral Hepatitis

  • ISSN

    1352-0504

  • e-ISSN

  • Volume of the periodical

    21

  • Issue of the periodical within the volume

    Supp. 1

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    26

  • Pages from-to

    34-59

  • UT code for WoS article

    000333893200003

  • EID of the result in the Scopus database